Gilly Regev

CEO

Gilly Regev picture

Gilly Regev

SaNOtize Research and Development Corp.

CEO

Dr. Regev is a biotech executive experienced in launching pharmaceutical enterprises. With her prior work experience, business skills and academic qualifications, Dr. Regev brings a wealth of expertise to her endeavors.

Dr. Regev co-founded SaNOtize in 2017 and has served as its Chief Executive Officer since incorporation. As CEO, she oversees all operations and business activities as well as all aspects of research from bench to clinical trials, regulatory affairs and intellectual property development. Under Dr. Regev’s leadership, the SaNOtize team has achieved considerable progress in the past 4 years, including out-licensing its technology for certain indications and securing equity and non-dilutional funding from well-known funders.

Dr. Regev has worked in the field of nitric oxide for the past 12 years, first at Nitric Solutions where she served as Director of R&D, and then later from 2012-2017 as the co-founder and Chief Scientific Officer for Bovico.